Oriola: Slides as pandemic hampers drugs distribution in Q2
17/07/2020 09:47
** Shares in Finnish drug wholesaler Oriola OKDBV.HE slump
9% after the company reported Q2 adjusted EBIT swinging to loss
amid COVID-19 pandemic urn:newsml:reuters.com:*:nFWN2EN176
** Oriola cites raised operational costs, which were aimed
at securing pharmaceutical deliveries, and restricted customer
mobility as reasons behind weakened profitability
** "The report was clearly below our expectations in terms
of revenue and especially profitability," Inderes analyst Petri
Kajaani says
** Kajaani adds he sees a significant downward pressure in
estimates for the current year after the report
** Oriola stock wipes off year-to-date gains
((boleslaw.lasocki@tr.com))